These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Nebulized colistin versus tobramycin in the treatment of chronic Pseudomonas colonization in cystic fibrosis patients]. Quintana-Gallego E, Lopez-Campos JL, Calero C, Dapena FJ. Med Clin (Barc); 2014 Jan 21; 142(2):59-63. PubMed ID: 23369499 [Abstract] [Full Text] [Related]
27. Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis. Smith AL, Fiel SB, Mayer-Hamblett N, Ramsey B, Burns JL. Chest; 2003 May 21; 123(5):1495-502. PubMed ID: 12740266 [Abstract] [Full Text] [Related]
32. Relationship between sputum inflammatory markers, lung function, and lung pathology on high-resolution computed tomography in children with cystic fibrosis. Dakin CJ, Pereira JK, Henry RL, Wang H, Morton JR. Pediatr Pulmonol; 2002 Jun 21; 33(6):475-82. PubMed ID: 12001282 [Abstract] [Full Text] [Related]
34. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa. Drobnic ME, Suñé P, Montoro JB, Ferrer A, Orriols R. Ann Pharmacother; 2005 Jan 21; 39(1):39-44. PubMed ID: 15562142 [Abstract] [Full Text] [Related]
35. Reduced mortality in cystic fibrosis patients treated with tobramycin inhalation solution. Sawicki GS, Signorovitch JE, Zhang J, Latremouille-Viau D, von Wartburg M, Wu EQ, Shi L. Pediatr Pulmonol; 2012 Jan 21; 47(1):44-52. PubMed ID: 21815282 [Abstract] [Full Text] [Related]